Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology (Q34763076)

4 August 2017

Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology (English)

1 reference

4 August 2017

0 references

1 reference

Frédérique Bard

1

1 reference

4 August 2017

Robin Barbour

2

1 reference

4 August 2017

Catherine Cannon

3

1 reference

4 August 2017

Robert Carretto

4

1 reference

4 August 2017

Michael Fox

5

1 reference

4 August 2017

Dora Games

6

1 reference

4 August 2017

Teresa Guido

7

1 reference

4 August 2017

Kathleen Hoenow

8

1 reference

4 August 2017

Kang Hu

9

1 reference

4 August 2017

Kelly Johnson-Wood

10

1 reference

4 August 2017

Karen Khan

11

1 reference

4 August 2017

Dora Kholodenko

12

1 reference

4 August 2017

Celeste Lee

13

1 reference

4 August 2017

Mike Lee

14

1 reference

4 August 2017

Ruth Motter

15

1 reference

4 August 2017

Minh Nguyen

16

1 reference

4 August 2017

Amanda Reed

17

1 reference

4 August 2017

Dale Schenk

18

1 reference

4 August 2017

Pearl Tang

19

1 reference

4 August 2017

Nicki Vasquez

20

1 reference

4 August 2017

Peter Seubert

21

1 reference

4 August 2017

Ted Yednock

22

1 reference

4 August 2017

language of work or name

English

0 references

publication date

3 February 2003

1 reference

Proceedings of the National Academy of Sciences of the United States of America

4 August 2017

1 reference

4 August 2017

100

1 reference

4 August 2017

2023-2028

1 reference

4 August 2017

4

1 reference

Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning

4 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

Epitopes involved in antibody-mediated protection from Ebola virus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

N-terminal EFRH sequence of Alzheimer's beta-amyloid peptide represents the epitope of its anti-aggregating antibodies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

Role of the B-cell response in recovery of mice from primary influenza virus infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

Disaggregation of Alzheimer beta-amyloid by site-directed mAb.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

FcR gamma chain deletion results in pleiotrophic effector cell defects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

Cutting edge: biasing immune responses by directing antigen to macrophage Fc gamma receptors.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=149952

Dosing in phase II trial of Alzheimer's vaccine suspended

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12566568

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12566568

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1073/PNAS.0436286100

1 reference

4 August 2017

0 references

1 reference

4 August 2017

1 reference